Yu-tian Cao
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comment on Huttasch et al. Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.
Journal: Diabetes care
Published: June 22, 2026
Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease via peroxisome proliferator-activated receptor alpha pathway activation.
Journal: World journal of gastroenterology
Published: September 30, 2025
Toward personalized patient selection for duodenal mucosal resurfacing in type 2 diabetes.
Journal: Gastrointestinal endoscopy
Published: September 17, 2025
Xietu Hemu Prescription Improves Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Cohort Study.
Journal: Journal of multidisciplinary healthcare
Published: March 20, 2025
Association between thyroid function and nonalcoholic fatty liver disease: a dose-response meta-analysis.
Journal: Frontiers in endocrinology
Published: March 12, 2024
Corrigendum: Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: February 15, 2023
Platelet abnormalities in autoimmune thyroid diseases: A systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: November 04, 2022
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Journal: EClinicalMedicine
Published: April 15, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026